SIMILAR PATTERNS OF AMINO ACIDS FOR 3NUO_B_478B478_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1g5u PROFILIN

(Hevea
brasiliensis)
PF00235
(Profilin)
5 ILE A1102
GLY A1104
ILE A1105
VAL A1032
ILE A1026
None
1.13A 3nuoA-1g5uA:
undetectable
3nuoA-1g5uA:
23.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  30
ILE A  47
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.58A 3nuoA-1hvcA:
13.9
3nuoA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  30
ILE A  47
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.61A 3nuoA-1hvcA:
13.9
3nuoA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
1.03A 3nuoA-1hvcA:
13.9
3nuoA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-3.6A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.81A 3nuoA-1hvcA:
13.9
3nuoA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.57A 3nuoA-1hvcA:
13.9
3nuoA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.49A 3nuoA-1hvcA:
13.9
3nuoA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  30
ILE A  47
GLY A  52
PRO A  81
VAL A  82
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
None
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
1.12A 3nuoA-1hvcA:
13.9
3nuoA-1hvcA:
46.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ik6 PYRUVATE
DEHYDROGENASE


(Pyrobaculum
aerophilum)
PF02779
(Transket_pyr)
PF02780
(Transketolase_C)
5 ILE A  67
GLY A  69
PRO A  81
VAL A  29
ILE A  58
None
0.95A 3nuoA-1ik6A:
undetectable
3nuoA-1ik6A:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1obb ALPHA-GLUCOSIDASE

(Thermotoga
maritima)
PF02056
(Glyco_hydro_4)
PF11975
(Glyco_hydro_4C)
6 ALA A  85
ILE A  40
GLY A  12
ILE A  48
VAL A  74
ILE A   9
NAD  A 500 (-3.5A)
NAD  A 500 (-3.9A)
NAD  A 500 (-3.0A)
None
None
None
1.47A 3nuoA-1obbA:
undetectable
3nuoA-1obbA:
13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1olx 2-OXOISOVALERATE
DEHYDROGENASE BETA
SUBUNIT


(Homo sapiens)
PF02779
(Transket_pyr)
PF02780
(Transketolase_C)
5 ALA B 226
ASP B 253
ILE B 326
VAL B 237
ILE B 234
None
0.92A 3nuoA-1olxB:
undetectable
3nuoA-1olxB:
16.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
None
0.63A 3nuoA-1q9pA:
9.9
3nuoA-1q9pA:
98.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rjb FL CYTOKINE RECEPTOR

(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 792
ILE A 921
GLY A 875
ILE A 876
PRO A 911
None
1.10A 3nuoA-1rjbA:
undetectable
3nuoA-1rjbA:
14.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
None
0.57A 3nuoA-1sivA:
18.6
3nuoA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
None
0.92A 3nuoA-1sivA:
18.6
3nuoA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.32A 3nuoA-1sivA:
18.6
3nuoA-1sivA:
50.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w25 STALKED-CELL
DIFFERENTIATION
CONTROLLING PROTEIN


(Caulobacter
vibrioides)
PF00072
(Response_reg)
PF00990
(GGDEF)
5 ALA A 114
GLY A 247
ILE A 246
VAL A 232
ILE A 251
None
1.06A 3nuoA-1w25A:
undetectable
3nuoA-1w25A:
13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zz3 HISTONE
DEACETYLASE-LIKE
AMIDOHYDROLASE


(Alcaligenaceae
bacterium FB188)
PF00850
(Hist_deacetyl)
5 ALA A 126
GLY A 302
ILE A 304
PRO A 258
VAL A 174
None
1.01A 3nuoA-1zz3A:
undetectable
3nuoA-1zz3A:
13.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  54
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
1.09A 3nuoA-2fmbA:
14.9
3nuoA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.50A 3nuoA-2fmbA:
14.9
3nuoA-2fmbA:
33.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2glw 92AA LONG
HYPOTHETICAL PROTEIN


(Pyrococcus
horikoshii)
no annotation 5 ALA A  54
GLY A  60
ILE A  18
VAL A  82
ILE A  37
None
1.01A 3nuoA-2glwA:
undetectable
3nuoA-2glwA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gm5 TRANSPOSON
GAMMA-DELTA
RESOLVASE


(Escherichia
coli)
PF00239
(Resolvase)
5 ALA A  26
ASP A  25
GLY A   5
ILE A  61
ILE A  93
None
1.04A 3nuoA-2gm5A:
undetectable
3nuoA-2gm5A:
23.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o1s 1-DEOXY-D-XYLULOSE-5
-PHOSPHATE SYNTHASE


(Escherichia
coli)
PF02779
(Transket_pyr)
PF02780
(Transketolase_C)
PF13292
(DXP_synthase_N)
5 ASP A  77
ALA A 154
ASP A 152
GLY A 158
ILE A 150
None
TDP  A3001 (-3.6A)
MG  A1001 ( 2.7A)
None
None
1.00A 3nuoA-2o1sA:
undetectable
3nuoA-2o1sA:
11.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pg0 ACYL-COA
DEHYDROGENASE


(Geobacillus
kaustophilus)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 ALA A 167
ASP A 168
ILE A  97
VAL A 172
ILE A 170
None
1.11A 3nuoA-2pg0A:
undetectable
3nuoA-2pg0A:
14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r7m 5-FORMAMINOIMIDAZOLE
-4-CARBOXAMIDE-1-(BE
TA)-D-RIBOFURANOSYL
5'-MONOPHOSPHATE
SYNTHETASE


(Methanocaldococcus
jannaschii)
PF06849
(DUF1246)
PF06973
(DUF1297)
5 ILE A   7
ILE A 291
PRO A  91
VAL A  90
ILE A  88
None
1.01A 3nuoA-2r7mA:
undetectable
3nuoA-2r7mA:
14.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.51A 3nuoA-2rkfA:
20.7
3nuoA-2rkfA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-4.2A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.86A 3nuoA-2rkfA:
20.7
3nuoA-2rkfA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.55A 3nuoA-2rkfA:
20.7
3nuoA-2rkfA:
81.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2v5i SALMONELLA
TYPHIMURIUM DB7155
BACTERIOPHAGE DET7
TAILSPIKE


(unidentified
phage)
PF09251
(PhageP22-tail)
5 ALA A 548
ILE A 580
ILE A 536
VAL A 543
ILE A 546
None
0.88A 3nuoA-2v5iA:
undetectable
3nuoA-2v5iA:
12.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vsi 2-C-METHYL-D-ERYTHRI
TOL 4-PHOSPHATE
CYTIDYLYLTRANSFERASE


(Streptococcus
pneumoniae)
PF01128
(IspD)
5 ALA A  95
ASP A  97
ILE A  93
GLY A   5
ILE A   6
None
1.09A 3nuoA-2vsiA:
undetectable
3nuoA-2vsiA:
18.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y23 MYOMESIN

(Homo sapiens)
PF07679
(I-set)
5 ASP A1401
GLY A1409
ILE A1410
VAL A1428
ILE A1389
None
0.87A 3nuoA-2y23A:
undetectable
3nuoA-2y23A:
15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y6p 3-DEOXY-MANNO-OCTULO
SONATE
CYTIDYLYLTRANSFERASE


(Aquifex
aeolicus)
PF02348
(CTP_transf_3)
5 ALA A   9
ASP A  95
ILE A  45
VAL A  57
ILE A  30
CTP  A1233 (-4.4A)
MG  A1234 ( 2.6A)
None
None
None
1.02A 3nuoA-2y6pA:
undetectable
3nuoA-2y6pA:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yg6 PUTRESCINE OXIDASE

(Rhodococcus
erythropolis)
PF01593
(Amino_oxidase)
5 ALA A 249
ASP A 250
GLY A  12
ILE A  10
ILE A 253
None
None
FAD  A 600 (-3.3A)
None
None
1.08A 3nuoA-2yg6A:
undetectable
3nuoA-2yg6A:
13.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aux DNA DOUBLE-STRAND
BREAK REPAIR RAD50
ATPASE


(Methanocaldococcus
jannaschii)
PF13476
(AAA_23)
5 ALA A 924
ILE A 963
ILE A 943
PRO A 948
ILE A 137
None
None
None
MG  A1050 (-4.0A)
None
1.13A 3nuoA-3auxA:
undetectable
3nuoA-3auxA:
14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fkj PUTATIVE
PHOSPHOSUGAR
ISOMERASES


(Salmonella
enterica)
PF01380
(SIS)
5 ALA A  99
ILE A  75
GLY A 102
ILE A 118
ILE A  15
None
0.76A 3nuoA-3fkjA:
undetectable
3nuoA-3fkjA:
13.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g25 GLYCEROL KINASE

(Staphylococcus
aureus)
PF00370
(FGGY_N)
PF02782
(FGGY_C)
5 ALA A 439
ILE A   8
GLY A  11
VAL A  29
ILE A  18
None
None
PO4  A 502 (-3.5A)
None
None
1.07A 3nuoA-3g25A:
undetectable
3nuoA-3g25A:
14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3it4 ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ ALPHA CHAIN
ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ BETA CHAIN


(Mycobacterium
tuberculosis)
PF01960
(ArgJ)
5 ASP B 241
ILE A 130
GLY A 128
PRO A  64
VAL A  65
None
0.96A 3nuoA-3it4B:
undetectable
3nuoA-3it4B:
19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3klj NAD(FAD)-DEPENDENT
DEHYDROGENASE,
NIRB-FAMILY
(N-TERMINAL DOMAIN)


(Clostridium
acetobutylicum)
PF07992
(Pyr_redox_2)
5 ASP A 129
ILE A 218
GLY A 152
ILE A 153
ILE A  49
None
1.13A 3nuoA-3kljA:
undetectable
3nuoA-3kljA:
15.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kzg ARGININE 3RD
TRANSPORT SYSTEM
PERIPLASMIC BINDING
PROTEIN


(Legionella
pneumophila)
PF00497
(SBP_bac_3)
5 ASP A  46
GLY A 208
ILE A  88
VAL A  83
ILE A  84
None
0.99A 3nuoA-3kzgA:
undetectable
3nuoA-3kzgA:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l4g PHENYLALANYL-TRNA
SYNTHETASE ALPHA
CHAIN
PHENYLALANYL-TRNA
SYNTHETASE BETA
CHAIN


(Homo sapiens)
PF01409
(tRNA-synt_2d)
PF03483
(B3_4)
PF03484
(B5)
5 ASP A 379
GLY B 319
ILE B 377
PRO A 415
ILE A 455
None
1.06A 3nuoA-3l4gA:
undetectable
3nuoA-3l4gA:
13.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mst PUTATIVE NITRATE
TRANSPORT PROTEIN


(Thermoplasma
volcanium)
PF12916
(DUF3834)
6 ALA A 171
ILE A 163
GLY A 191
ILE A 192
PRO A  10
ILE A 174
None
None
None
None
ACT  A 232 (-4.6A)
None
1.20A 3nuoA-3mstA:
undetectable
3nuoA-3mstA:
19.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
None
0.56A 3nuoA-3mwsA:
20.2
3nuoA-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  48
PRO A  81
VAL A  82
ILE A  84
None
0.94A 3nuoA-3mwsA:
20.2
3nuoA-3mwsA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nut PRECORRIN-3
METHYLASE


(Rhodobacter
capsulatus)
PF00590
(TP_methylase)
5 ALA A 212
ASP A 211
ILE A 180
VAL A 225
ILE A 191
None
1.12A 3nuoA-3nutA:
undetectable
3nuoA-3nutA:
15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o07 PYRIDOXINE
BIOSYNTHESIS PROTEIN
SNZ1


(Saccharomyces
cerevisiae)
PF01680
(SOR_SNZ)
5 ILE A 166
GLY A 132
PRO A 206
VAL A 207
ILE A 145
None
1.12A 3nuoA-3o07A:
undetectable
3nuoA-3o07A:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rxy NIF3 PROTEIN

(Sphaerobacter
thermophilus)
no annotation 5 ALA A 167
ASP A 163
ILE A 165
VAL A 197
ILE A 148
None
1.12A 3nuoA-3rxyA:
undetectable
3nuoA-3rxyA:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sze SERINE PROTEASE ESPP

(Escherichia
coli)
PF02395
(Peptidase_S6)
5 ALA A 723
ILE A 708
ILE A 655
VAL A 648
ILE A 667
None
1.02A 3nuoA-3szeA:
undetectable
3nuoA-3szeA:
7.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
017  A 201 (-2.6A)
017  A 201 (-3.5A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.81A 3nuoA-3t3cA:
18.5
3nuoA-3t3cA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ILE A  47
GLY A  49
PRO A  81
017  A 201 (-2.6A)
017  A 201 (-3.5A)
None
017  A 201 (-4.0A)
None
1.10A 3nuoA-3t3cA:
18.5
3nuoA-3t3cA:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tsn 4-HYDROXYTHREONINE-4
-PHOSPHATE
DEHYDROGENASE


(Campylobacter
jejuni)
PF04166
(PdxA)
5 ALA A  44
ILE A   8
GLY A  15
ILE A  14
ILE A  96
None
1.06A 3nuoA-3tsnA:
undetectable
3nuoA-3tsnA:
18.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.70A 3nuoA-3ttpA:
19.6
3nuoA-3ttpA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.4A)
None
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.93A 3nuoA-3ttpA:
19.6
3nuoA-3ttpA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  30
ILE A  47
PRO A  81
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-4.0A)
0.67A 3nuoA-3u7sA:
19.9
3nuoA-3u7sA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.83A 3nuoA-3u7sA:
19.9
3nuoA-3u7sA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zuz PROTEIN SHQ1

(Saccharomyces
cerevisiae)
PF04925
(SHQ1)
5 ALA A 409
ILE A 271
GLY A 402
VAL A 252
ILE A 251
None
1.03A 3nuoA-3zuzA:
undetectable
3nuoA-3zuzA:
14.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bed HEMOCYANIN KLH1

(Megathura
crenulata)
PF00264
(Tyrosinase)
PF14830
(Haemocyan_bet_s)
5 ALA B2984
ASP B3152
ILE B2979
ILE B3104
ILE B2942
None
0.94A 3nuoA-4bedB:
undetectable
3nuoA-4bedB:
4.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c30 DNA HELICASE II

(Deinococcus
radiodurans)
PF00580
(UvrD-helicase)
PF13361
(UvrD_C)
5 ALA A 180
GLY A 130
ILE A 135
VAL A 143
ILE A 144
None
1.09A 3nuoA-4c30A:
undetectable
3nuoA-4c30A:
9.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4czb NA(+)/H(+)
ANTIPORTER 1


(Methanocaldococcus
jannaschii)
PF00999
(Na_H_Exchanger)
5 ASP A  31
ILE A 137
PRO A 346
VAL A 398
ILE A  32
None
1.10A 3nuoA-4czbA:
undetectable
3nuoA-4czbA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89


(synthetic
construct)
PF00768
(Peptidase_S11)
PF07943
(PBP5_C)
5 ALA A  76
GLY A 112
ILE A 107
VAL A  98
ILE A  72
None
1.10A 3nuoA-4drtA:
undetectable
3nuoA-4drtA:
15.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eex ALCOHOL
DEHYDROGENASE 1


(Lactococcus
lactis)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 ALA A 242
ILE A 196
GLY A 171
PRO A 220
ILE A 244
None
1.13A 3nuoA-4eexA:
undetectable
3nuoA-4eexA:
15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fs7 UNCHARACTERIZED
PROTEIN


(Bacteroides
ovatus)
PF13306
(LRR_5)
5 ALA A 177
ILE A 142
PRO A 167
VAL A 170
ILE A 173
None
1.13A 3nuoA-4fs7A:
undetectable
3nuoA-4fs7A:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gm6 PFKB FAMILY
CARBOHYDRATE KINASE


(Listeria grayi)
PF00294
(PfkB)
5 ALA A  40
GLY A  33
ILE A  32
VAL A  79
ILE A  52
None
GOL  A 401 ( 4.1A)
None
None
None
1.06A 3nuoA-4gm6A:
undetectable
3nuoA-4gm6A:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gvl TRKA DOMAIN PROTEIN

(Geobacter
sulfurreducens)
PF02080
(TrkA_C)
PF02254
(TrkA_N)
5 ALA A 365
ILE A 356
GLY A 256
ILE A 257
ILE A 362
None
None
None
None
AMP  A 602 (-4.3A)
1.12A 3nuoA-4gvlA:
undetectable
3nuoA-4gvlA:
11.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4im7 HYPOTHETICAL
OXIDOREDUCTASE YDFI


(Escherichia
coli)
PF01232
(Mannitol_dh)
PF08125
(Mannitol_dh_C)
5 ALA A 201
ASP A 205
GLY A 161
VAL A 216
ILE A 212
None
1.13A 3nuoA-4im7A:
undetectable
3nuoA-4im7A:
11.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jqp 4-HYDROXYTHREONINE-4
-PHOSPHATE
DEHYDROGENASE


(Paraburkholderia
phymatum)
PF04166
(PdxA)
5 ASP A 128
GLY A 210
ILE A 211
VAL A 300
ILE A 305
None
1.08A 3nuoA-4jqpA:
undetectable
3nuoA-4jqpA:
15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m1q L-LACTATE
DEHYDROGENASE


([Bacillus]
selenitireducens)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 ILE A 148
GLY A 144
ILE A 119
VAL A  16
ILE A 236
None
1.11A 3nuoA-4m1qA:
undetectable
3nuoA-4m1qA:
15.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.44A 3nuoA-4njvA:
20.9
3nuoA-4njvA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.84A 3nuoA-4njvA:
20.9
3nuoA-4njvA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p80 ANCESTRAL PYRR
PROTEIN (GREEN)


(synthetic
construct)
PF00156
(Pribosyltran)
5 ASP A   9
ILE A  13
GLY A 150
ILE A 149
VAL A 161
None
0.92A 3nuoA-4p80A:
undetectable
3nuoA-4p80A:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q2n INAD-LIKE PROTEIN

(Homo sapiens)
PF00595
(PDZ)
5 ASP A 416
ILE A 412
GLY A 377
VAL A 421
ILE A 418
None
1.13A 3nuoA-4q2nA:
undetectable
3nuoA-4q2nA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q6g PYRROLYSINE--TRNA
LIGASE


(Methanosarcina
mazei)
PF01409
(tRNA-synt_2d)
5 ASP A 408
ILE A 305
GLY A 419
ILE A 418
ILE A 413
None
ALY  A 508 ( 4.6A)
ALY  A 508 ( 4.3A)
None
EDO  A 506 ( 4.7A)
1.03A 3nuoA-4q6gA:
undetectable
3nuoA-4q6gA:
16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qi3 CELLOBIOSE
DEHYDROGENASE


(Crassicarpon
hotsonii)
PF16010
(CDH-cyt)
5 ASP A 161
GLY A  67
ILE A  80
PRO A 102
ILE A 171
None
HEM  A 401 (-3.5A)
None
HEM  A 401 ( 4.7A)
None
1.13A 3nuoA-4qi3A:
undetectable
3nuoA-4qi3A:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4twb RIBOSE-PHOSPHATE
PYROPHOSPHOKINASE


(Sulfolobus
solfataricus)
PF00156
(Pribosyltran)
PF13793
(Pribosyltran_N)
5 ASP A 217
ILE A 245
GLY A 267
ILE A 279
ILE A 215
None
1.02A 3nuoA-4twbA:
undetectable
3nuoA-4twbA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4w7h CARBONYL REDUCTASE

(Sphingomonas
sp. A1)
PF13561
(adh_short_C2)
5 ALA A 167
GLY A 149
ILE A 191
VAL A 122
ILE A 118
None
1.12A 3nuoA-4w7hA:
undetectable
3nuoA-4w7hA:
18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wzz PUTATIVE SUGAR ABC
TRANSPORTER,
SUBSTRATE-BINDING
PROTEIN


(Lachnoclostridium
phytofermentans)
PF13407
(Peripla_BP_4)
5 ALA A 178
ILE A 167
GLY A 268
ILE A 248
VAL A 264
None
1.06A 3nuoA-4wzzA:
undetectable
3nuoA-4wzzA:
13.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 792
ILE A 921
GLY A 875
ILE A 876
PRO A 911
None
1.12A 3nuoA-4xufA:
undetectable
3nuoA-4xufA:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yry DIHYDROPYRIMIDINE
DEHYDROGENASE
SUBUNIT A


(Thermotoga
maritima)
PF07992
(Pyr_redox_2)
PF14691
(Fer4_20)
5 ILE B 113
GLY B  87
PRO B  52
VAL B  53
ILE B  55
SF4  B 502 ( 4.8A)
None
SF4  B 502 ( 4.9A)
None
SF4  B 502 ( 4.4A)
1.02A 3nuoA-4yryB:
undetectable
3nuoA-4yryB:
14.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a6s ENDOLYSIN

(Clostridium
phage phiCTP1)
PF01183
(Glyco_hydro_25)
5 ASP A   6
ILE A 181
ILE A 142
VAL A  90
ILE A  28
SO4  A1274 (-4.0A)
None
None
None
None
0.95A 3nuoA-5a6sA:
undetectable
3nuoA-5a6sA:
15.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bwi GLYCOSIDE HYDROLASE
FAMILY 79


(Burkholderia
pseudomallei)
PF12891
(Glyco_hydro_44)
5 ALA A 330
ASP A 444
ILE A 324
VAL A 364
ILE A 362
None
0.94A 3nuoA-5bwiA:
undetectable
3nuoA-5bwiA:
13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5chc DMSO REDUCTASE
FAMILY TYPE II
ENZYME,
MOLYBDOPTERIN
SUBUNIT


(Azospira oryzae)
PF00384
(Molybdopterin)
PF01568
(Molydop_binding)
5 ALA A 809
ILE A 817
GLY A 846
PRO A 787
ILE A 789
None
0.95A 3nuoA-5chcA:
undetectable
3nuoA-5chcA:
8.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5csa ACETYL-COA
CARBOXYLASE


(Saccharomyces
cerevisiae)
PF00364
(Biotin_lipoyl)
PF08326
(ACC_central)
5 ALA A1361
ILE A1385
GLY A1340
ILE A1341
ILE A1425
None
1.12A 3nuoA-5csaA:
undetectable
3nuoA-5csaA:
7.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5csl ACETYL-COA
CARBOXYLASE


(Saccharomyces
cerevisiae)
PF00289
(Biotin_carb_N)
PF00364
(Biotin_lipoyl)
PF01039
(Carboxyl_trans)
PF02785
(Biotin_carb_C)
PF02786
(CPSase_L_D2)
PF08326
(ACC_central)
5 ALA A1361
ILE A1385
GLY A1340
ILE A1341
ILE A1425
None
1.10A 3nuoA-5cslA:
undetectable
3nuoA-5cslA:
4.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cy1 TRANSPOSON TN3
RESOLVASE


(Escherichia
coli)
PF00239
(Resolvase)
PF02796
(HTH_7)
5 ALA A  26
ASP A  25
GLY A   5
ILE A  61
ILE A  93
None
1.08A 3nuoA-5cy1A:
undetectable
3nuoA-5cy1A:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d3m ENERGY-COUPLING
FACTOR TRANSPORTER
ATP-BINDING PROTEIN
ECFA1


(Lactobacillus
delbrueckii)
PF00005
(ABC_tran)
5 ALA A 153
GLY A  87
ILE A 166
VAL A 186
ILE A 154
None
1.03A 3nuoA-5d3mA:
undetectable
3nuoA-5d3mA:
17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dh2 SIDEROPHORE
PERIPLASMIC BINDING
PROTEIN


(Thermobifida
fusca)
PF01497
(Peripla_BP_2)
5 ASP A 177
ILE A 174
ILE A 160
VAL A 139
ILE A 151
None
1.09A 3nuoA-5dh2A:
undetectable
3nuoA-5dh2A:
18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jfc NADH-DEPENDENT
FERREDOXIN:NADP
OXIDOREDUCTASE
SUBUNIT ALPHA


(Pyrococcus
furiosus)
PF07992
(Pyr_redox_2)
PF14691
(Fer4_20)
5 ILE L 122
GLY L  98
PRO L  57
VAL L  58
ILE L  60
SF4  L 501 ( 4.6A)
SF4  L 501 ( 4.5A)
None
None
SF4  L 501 ( 4.4A)
1.05A 3nuoA-5jfcL:
undetectable
3nuoA-5jfcL:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n4c PROLYL
OLIGOPEPTIDASE


(Galerina
marginata)
no annotation 6 ALA A 598
ILE A 655
GLY A 580
PRO A 640
VAL A 588
ILE A 587
None
1.39A 3nuoA-5n4cA:
undetectable
3nuoA-5n4cA:
7.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nfb GALECTIN-3

(Homo sapiens)
PF00337
(Gal-bind_lectin)
5 ALA A 156
ASP A 154
GLY A 235
VAL A 126
ILE A 231
None
1.10A 3nuoA-5nfbA:
undetectable
3nuoA-5nfbA:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5oyn DEHYDRATASE,
ILVD/EDD FAMILY


(Caulobacter
vibrioides)
no annotation 5 ALA A 249
ASP A 120
ILE A 144
ILE A 258
ILE A 245
None
1.01A 3nuoA-5oynA:
undetectable
3nuoA-5oynA:
20.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
ILE A  47
PRO A  81
ILE A  84
None
0.60A 3nuoA-5t2zA:
20.1
3nuoA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.55A 3nuoA-5t2zA:
20.1
3nuoA-5t2zA:
81.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vj7 OXIDOREDUCTASE

(Pyrococcus
furiosus)
PF07992
(Pyr_redox_2)
PF14691
(Fer4_20)
5 ILE A 122
GLY A  98
PRO A  57
VAL A  58
ILE A  60
SF4  A 501 ( 4.7A)
SF4  A 501 ( 4.4A)
None
None
SF4  A 501 ( 4.6A)
1.09A 3nuoA-5vj7A:
undetectable
3nuoA-5vj7A:
15.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vlj NUCLEAR DISTRIBUTION
PROTEIN PAC1


(Saccharomyces
cerevisiae)
PF00400
(WD40)
5 ASP B 351
ILE B 355
GLY B 447
VAL B 374
ILE B 425
None
1.08A 3nuoA-5vljB:
undetectable
3nuoA-5vljB:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wu7 UNCHARACTERIZED
PROTEIN


(Pyrococcus
horikoshii)
PF03065
(Glyco_hydro_57)
PF09210
(DUF1957)
5 ALA A 259
ILE A 387
GLY A 180
ILE A 181
VAL A 222
None
0.97A 3nuoA-5wu7A:
undetectable
3nuoA-5wu7A:
11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wzr ALPHA-N-ACETYLGALACT
OSAMINIDASE


(Bifidobacterium
bifidum)
PF11308
(Glyco_hydro_129)
5 ASP A 554
ASP A 561
GLY A 323
ILE A 274
VAL A 270
None
DJN  A 702 (-2.9A)
None
None
None
1.11A 3nuoA-5wzrA:
undetectable
3nuoA-5wzrA:
10.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x4j UNCHARACTERIZED
PROTEIN


(Pyrococcus
furiosus)
no annotation 5 ALA A 429
GLY A 423
PRO A 391
VAL A 359
ILE A 460
None
1.13A 3nuoA-5x4jA:
undetectable
3nuoA-5x4jA:
19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b3e CYCLIN-DEPENDENT
KINASE 12


(Homo sapiens)
no annotation 5 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
None
0.97A 3nuoA-6b3eA:
undetectable
3nuoA-6b3eA:
22.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
0.58A 3nuoA-6upjA:
17.8
3nuoA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
0.99A 3nuoA-6upjA:
17.8
3nuoA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
0.75A 3nuoA-6upjA:
17.8
3nuoA-6upjA:
48.48